Some medicines used in MS, including disease modifying drugs (DMDs), are manufactured in mainland Europe. The government has recognised that there is concern around getting these medicines into Britain if there is a no-deal Brexit, or if there is disruption around Brexit at the end of October.
The NHS England information webpage describes the arrangements that have been made to ensure that medicines remain accessible if there is a no-deal EU exit. This information is not specific to MS medication.
Existing Brexit arrangements include holding an extra six weeks of medicine stocks in the UK, as a buffer against an interruption in medicine supply, and ensuring extra transport capacity to get medicines into the UK.
Government recommendations for people who require medicines are as follows:
Get your prescription medicines as normal.
Keep ordering your repeat prescriptions, and take your medicines as recommended by your doctors. There is no need to change how often you order your medicines, how much of your medicines you order, or how frequently you take your medicines.
Don’t stockpile your own medicines.
If there is a shortage of your medicine, you might temporarily be prescribed with a different brand or formulation of the medicine to the one you are used to. You and the doctor who prescribed your medicine should be informed and be able to discuss your options for continuing treatment.
Your clinical trial
Some clinical trials involve research centres across Europe. If you are concerned that your clinical trial might be interrupted by Brexit, speak to the NHS organisation that is hosting the trial.
Your medications in the future
Currently, the European Medicines Agency is responsible for licensing new medicines. We don't yet know what the future relationship between the UK and the European Medicines Agency will be. The government is amending drug regulations to ensure that medicines, devices and clinical trials licensed or tested in the EU can continue to be used in the UK.
Prescription medicines are currently free in Scotland, Wales and Northern Ireland, and there is a small charge per prescription item in England. We have no indication that there will be a price rise following Brexit.
Find out about research currently happening in MS, how to get involved, drugs in development and more.
Read the latest in MS
Find out about the latest news and research surrounding MS, plus features and blogs from MS Trust staff and health professionals.
About the MS Trust
We're a UK charity dedicated to making life better for people living with multiple sclerosis. Find out more about us and what we're doing to support people with MS.